PULM (pulmatrix.com) יחס שווי שוק לשווי בספרים

This daily price chart for Pulmatrix, Inc. (PULM), whose biopharmaceutical operations rely on stable demand but depend on uninterrupted raw material imports, reflects the value 3.29. In the respiratory devices segment, the firm competes for market share against resource-rich behemoths, while the business faces uncertainty regarding the timing of patent-derived profits and significant ongoing research expenditures.

An investor determines an asset's margin of safety by comparing the market price to the actual net asset value. The pharmaceutical line robotics of Pulmatrix, Inc. (PULM) create a high-tech asset base that impacts the book value. The trend of the market-to-book ratio demonstrates the premium or discount coefficient to equity. A value above one confirms market confidence in future earnings, while a low level indicates undervaluation. This metric classifies the asset by its degree of fundamental risk.